IOVA - Iovance Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.11
DETAILS
HIGH:
$20.00
LOW:
$5.00
MEDIAN:
$15.00
CONSENSUS:
$13.11
DOWNSIDE:
10.33%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 0 | $0 | -- | -8,016,353 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-30 | Berkowitz Noah | officer: Chief Medical Officer | A-Award | 180,000 | -- | -- |
| 2026-09-30 | Berkowitz Noah | officer: Chief Medical Officer | A-Award | 135,000 | -- | -- |
| 2026-09-30 | Berkowitz Noah | officer | ? | -- | -- | -- |
| 2026-09-08 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 6,638 | $8.70 | $58K |
| 2026-09-08 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 15,626 | -- | -- |
| 2026-09-08 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 7,813 | -- | -- |
| 2026-09-08 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 3,976 | $8.70 | $35K |
| 2026-09-08 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 9,766 | -- | -- |
| 2026-09-08 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 4,478 | $8.70 | $39K |
| 2026-09-01 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2,508 | $8.28 | $21K |
| 2026-09-01 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5,470 | -- | -- |
| 2026-09-01 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 4,472 | $8.28 | $37K |
| 2026-09-01 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8,789 | -- | -- |
| 2026-09-01 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41,669 | -- | -- |
| 2026-09-01 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 17,702 | $8.28 | $147K |
| 2026-08-10 | Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 2,436 | $6.40 | $16K |
| 2026-08-10 | Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 10,001 | -- | -- |
| 2026-08-06 | Roche Corleen M. | officer: Chief Financial Officer | F-InKind | 21,238 | $6.21 | $132K |
| 2026-08-06 | Roche Corleen M. | officer: Chief Financial Officer | M-Exempt | 49,995 | -- | -- |
| 2026-06-16 | WEISER MICHAEL | director | A-Award | 90,316 | -- | -- |
| 2026-06-16 | Maynard Ryan D | director | A-Award | 90,316 | -- | -- |
| 2026-06-16 | Puri Raj K. | officer: Chief Regulatory Officer | A-Award | 15,000 | -- | -- |
| 2026-06-16 | Dukes Iain D. | director | A-Award | 180,632 | -- | -- |
| 2026-06-16 | Countouriotis Athena | director | A-Award | 90,316 | -- | -- |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 3,976 | $4.23 | $17K |